Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Givlaari, Rybelsus lead crowded CHMP recommendations

Givlaari, Rybelsus lead crowded CHMP recommendations

Lilly’s SGLT2 inibitor Jardiance (empagliflozin) and Victoza, as well as placebo.

Novo bolstered by new diabetes, obesity products

Novo bolstered by new diabetes, obesity products The once-weekly injectable GLP-1 agonist has continued to offset declines of Novo’s older drugs, including the one-daily shot Victoza (liraglutide).

Novo Nordisk gets FDA okay for new diabetes hope

Novo Nordisk gets FDA okay for new diabetes hope Sales of Victoza fell 5% in the first half of the year to around $1.6bn, and while the decline was more than offset by growth by Ozempic’s $550m contribution ... to Reuters, and that would make it a larger product than Victoza at its peak.

Novo Nordisk shareholder revolt reaches Europe

Novo Nordisk shareholder revolt reaches Europe Novo Nordisk has latterly become less reliant on sales of its insulin products as newer products, particularly GLP-1 agonists Victoza (liraglutide) and Ozempic (semaglutide), have increased their share of revenues.

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%

Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12% Trulicity's growth to date has stemmed largely from its once-weekly dosing, which proved a popular alternative to daily GLP-1 agonists such as Novo Nordisk's older drug Victoza ... empagliflozin) equivalent to once-daily injectable Victoza at both six-

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics